These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 17125716)

  • 21. Menopausal hormone therapy: is there evidence for cardiac protection?
    Wenger NK
    Int Urol Nephrol; 2004; 36(4):617-23. PubMed ID: 15787348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Update: estrogen and estrogen plus progestin therapy in the care of women at and after the menopause.
    Davey DA
    Womens Health (Lond); 2012 Mar; 8(2):169-89. PubMed ID: 22375720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of SERM on breast cancer and cardiovascular disease: making a comparison between raloxifene use and hormone replacement therapy on the risks of the diseases].
    Higuchi T; Mizunuma H
    Clin Calcium; 2004 Oct; 14(10):81-4. PubMed ID: 15577136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Menopausal hormone therapy for cardiovascular protection--unfulfilled expectations.
    Wenger NK
    J Cardiovasc Transl Res; 2009 Sep; 2(3):286-8. PubMed ID: 20560017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progesterone vs. synthetic progestins and the risk of breast cancer: a systematic review and meta-analysis.
    Asi N; Mohammed K; Haydour Q; Gionfriddo MR; Vargas OL; Prokop LJ; Faubion SS; Murad MH
    Syst Rev; 2016 Jul; 5(1):121. PubMed ID: 27456847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hormone therapy and selective estrogen receptor modulators for prevention of coronary heart disease in postmenopausal women estrogen replacement from the cardiologist's perspective.
    Mobasseri S; Liebson PR; Klein LW
    Cardiol Rev; 2004; 12(6):287-98. PubMed ID: 15476565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postmenopausal hormone therapy: cardiovascular risks.
    Prescrire Int; 2003 Apr; 12(64):65-9. PubMed ID: 12674130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent concerns surrounding HRT.
    Armitage M; Nooney J; Evans S
    Clin Endocrinol (Oxf); 2003 Aug; 59(2):145-55. PubMed ID: 12864790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The menopause: benefits and risks of estrogen-progestogen replacement therapy.
    Gambrell RD
    Fertil Steril; 1982 Apr; 37(4):457-74. PubMed ID: 7040116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The menopause and HRT. Hormone replacement therapy, cardiovascular and cerebrovascular disease.
    Teede HJ
    Best Pract Res Clin Endocrinol Metab; 2003 Mar; 17(1):73-90. PubMed ID: 12763513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Menopausal hormone therapy: a paradigm shift?
    Liu JH
    Fertil Steril; 2003 Sep; 80(3):494-5. PubMed ID: 12969685
    [No Abstract]   [Full Text] [Related]  

  • 32. Use of menopausal hormone therapy beyond age 65 years and its effects on women's health outcomes by types, routes, and doses.
    Baik SH; Baye F; McDonald CJ
    Menopause; 2024 May; 31(5):363-371. PubMed ID: 38595196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adverse neoplastic and cardiovascular outcomes of HRT: the validity of the evidence.
    Shapiro S
    Endocrine; 2004 Aug; 24(3):203-10. PubMed ID: 15542886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A review of menopausal hormone therapy: recalibrating the balance of benefit and risk.
    Rajan S; Kreatsoulas C
    Pol Arch Intern Med; 2019 Apr; 129(4):276-280. PubMed ID: 30608056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Baseline characteristics of participants in the Raloxifene Use for The Heart (RUTH) trial.
    Wenger NK; Barrett-Connor E; Collins P; Grady D; Kornitzer M; Mosca L; Sashegyi A; Baygani SK; Anderson PW; Moscarelli E
    Am J Cardiol; 2002 Dec; 90(11):1204-10. PubMed ID: 12450599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Specific estrogen receptor modulators (SERMs)].
    Trémollières F; Lopes P
    Presse Med; 2002 Sep; 31(28):1323-8. PubMed ID: 12355995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The medical management of menopause: to treat or not to treat?
    Barlow DH
    Ann N Y Acad Sci; 2008 Apr; 1127():134-9. PubMed ID: 18443341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of cardiovascular disease in relation to the use of combined postmenopausal hormone therapy: detection bias and resolution of discrepant findings in two Women's Health Initiative studies.
    Shapiro S
    Climacteric; 2006 Dec; 9(6):416-20. PubMed ID: 17085373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective estrogen receptor modulation and reduction in risk of breast cancer, osteoporosis, and coronary heart disease.
    Jordan VC; Gapstur S; Morrow M
    J Natl Cancer Inst; 2001 Oct; 93(19):1449-57. PubMed ID: 11584060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The controversy over estrogen replacement therapy: an update on clinical trials.
    Gnatuk CL
    Curr Womens Health Rep; 2002 Apr; 2(2):89-94. PubMed ID: 12116607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.